Events

Rappel de Device Recall PCA 3

Selon U.S. Food and Drug Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à United States qui a été fabriqué par Hospira Inc..

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    68318
  • Classe de risque de l'événement
    Class 2
  • Numéro de l'événement
    Z-2140-2016
  • Date de mise en oeuvre de l'événement
    2013-03-08
  • Statut de l'événement
    Terminated
  • Pays de l'événement
    United States
  • Date de fin de l'événement
    2016-11-07
  • Source de l'événement
    USFDA
  • URL de la source de l'événement
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=127329
  • Notes / Alertes
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
    ICU Medical, Inc. acquired from Pfizer in early 2017, Hospira Infusion Systems, the portion of Hospira dedicated to develop infusion pumps.
  • Notes supplémentaires dans les données
    Pump, infusion, pca - Product Code MEA
  • Cause
    Hospira has received reports of pca pumps not detecting distal occlusions, one of which resulted in a serious injury. the issue is caused by normal wear and tear on the half nut (the component/nut that travels up and down the lead screw) which prevents it from properly detecting the pressure build-up associated with a distal occlusion.
  • Action
    Hospira sent an IMPORTANT DEVICE INFORMATION letter dated March 8, 2014 to all affected customers.. The letter advised customers to: 1) Perform the Performance Verification Test (PVT) Occlusion Test as defined in the PCA Technical Service Manual (TSM); 2) If the device does not pass the test, remove it from clinical service and contact Hospira at 800-441-4100 (Monday - Friday, 8:00 AM - 5:00 PM CST) to report the issue; and 3) Perform the appropriate troubleshooting and repair activities defined by your facility, which may include returning the device to Hospira for further diagnosing and servicing. The letter advised the Hospira is in the process of establishing a useful life for the half nut and to determine when it will require replacement. A new Technical Service Manual will be issued in late 2014 that adds a requirement for annual PVT Occlusion testing. The System Operating Manual will include new instructions to reduce the excessive wear on the half nut resulting from incorrectly using the vial information. Customers who further distributed the devices are requested to notify their customers of the recall and ask them to call Stericycle at 888-965-5801 (Monday - Friday, 8:00 AM - 5:00 PM EST) to receive a reply form. Questions about this recall should be direct to Hospira at 800-441-4100 (Monday - Friday, 8:00 AM - 5:00 PM CST).

Device

Device Recall PCA 3
  • Modèle / numéro de série
  • Classification du dispositif
    General Hospital and Personal Use Devices
  • Classe de dispositif
    2
  • Dispositif implanté ?
    No
  • Distribution
    Nationwide Distribution to AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY) + District of Columbia + Puerto Rico + Virgin Islands; *** FOREIGN:
  • Description du dispositif
    The PCA 3 system cam be used in a wide range of clinical settings, including but not limited to: general floor, labor/delivery,post-partum, burn unit, medical surgical, operating room, oncology, critical care units, post-anesthesia care unit (PACU), and pediatrics. The PCA 3 infusion pump allows clinicians to administer or patients to self-administer analgesia safely and effectively within clinician programmed limits. The epidural route can be used to provide anesthesia or analgesia.
  • Manufacturer
    Hospira Inc.

Manufacturer

Hospira Inc.
  • Adresse du fabricant
    Hospira Inc., 275 N Field Dr, Lake Forest IL 60045-2579
  • Société-mère du fabricant (2017)
    Pfizer
  • Source
    USFDA